Latest News

Cannabis stocks, including Curaleaf Holdings, recently jumped after reports that former President Trump plans to direct U.S. federal agencies to ease marijuana restrictions, potentially reclassifying cannabis as a less-dangerous drug. This potential shift in the federal legal framework could be especially important for Curaleaf, which has built its business model around operating at scale in tightly regulated cannabis markets. We’ll now explore how the prospect of U.S. federal cannabis...

W.W. Grainger (GWW) has quietly pushed higher in recent weeks, with the stock up about 7% over the past week and roughly 11% in the past month after a tough start to the year. See our latest analysis for W.W. Grainger. That bounce has only partly repaired the damage from earlier in the year, with the year to date share price return still slightly negative and the 1 year total shareholder return in the red. However, multi year total shareholder returns remain very strong, suggesting long term...

WEC Energy Group (WEC) just paired fresh 2026 earnings guidance with plans for a higher 2026 dividend, sending a clear signal about management’s confidence in both cash flow durability and long term growth. See our latest analysis for WEC Energy Group. The guidance and dividend news land after a choppy stretch, with a negative 30 day share price return but an 11.99% year to date share price return and resilient 5 year total shareholder return of 39.05%, suggesting steady compounding rather...

Nagoya Railroad (TSE:9048) has hit the brakes on its flagship Nagoya Station District Redevelopment and Meitetsu Nagoya Station Renovation projects, after a board meeting revealed delays tied to higher construction costs and contractor shortages. See our latest analysis for Nagoya Railroad. The news lands after a softer stretch for investors, with the share price at ¥1,626 and a negative 1 year total shareholder return contrasting with modest recent share price gains. This suggests sentiment...

SpareBank 1 Sør-Norge has recently continued its 2026 employee share savings programme, allowing staff to invest NOK 6,000–60,000 annually in discounted shares with a two-year lock-in, while also progressing a previously announced buy-back of up to 1% of its own shares. Together, the buy-back and discounted employee share scheme highlight management’s emphasis on ownership alignment and capital return alongside operational and growth objectives. We’ll now examine how the ongoing share...

Biogen (BIIB) has been back in the spotlight after fresh data on two key neurology programs, zorevunersen for Dravet syndrome and subcutaneous lecanemab for Alzheimer’s, landed at major medical meetings this month. See our latest analysis for Biogen. Those upbeat data drops seem to be breathing life back into sentiment, with a 21.31 percent 3 month share price return and a stronger 1 year total shareholder return of 16.66 percent, even though the 5 year total shareholder return of negative...

Mohawk Industries (MHK) is back in the spotlight as fresh analysis points to two years of stalled organic revenue growth, weakening returns on invested capital, and disappointing cash conversion. This is sharpening questions around its long term strategy. See our latest analysis for Mohawk Industries. Despite a modest 1 month share price return of 4.24 percent and a 7 day share price gain of 2.57 percent, the 1 year total shareholder return of negative 12.01 percent and 5 year total...

Gartner (IT) just caught investors attention again after a director bought shares and management authorized a record $1 billion buyback, which some see as a signal of confidence even as growth and margins face pressure. See our latest analysis for Gartner. The latest bounce, including a 5.33% 1 day share price return and 8.39% 7 day share price return to $246.35, has eased some nerves. However, it comes after a brutal year to date share price decline of 49.03 percent and a 1 year total...

MPLX (MPLX) has quietly outperformed much of the midstream space over the past year, and that kind of steady climb usually signals investors see more than just a generous payout. See our latest analysis for MPLX. At a share price of about $54.90, MPLX has logged a solid 12.9 percent year to date share price return, while its 24.4 percent one year total shareholder return suggests momentum is still building rather than fading. If MPLX's steady climb has you thinking about broader income and...

Casio Computer Ltd (TSE:6952) just leaned into its G SHOCK heritage with the new GMWBZ5000 full metal lineup, an AI engineered evolution of the classic 5000 series launched ahead of the holiday season. See our latest analysis for Casio ComputerLtd. Despite this high profile G SHOCK launch, Casio ComputerLtd’s share price return has been modest, with a roughly low single digit gain over the past quarter and year to date. Multi year total shareholder returns remain subdued, which hints that...

Xenia Hotels & Resorts recently completed a major share repurchase program, buying back 3,717,939 shares for US$48.91 million between July 1 and December 4, 2025, and in total retiring 28,230,533 shares for US$377.5 million since the program began in 2015. By shrinking its share count by over a quarter through this long-running buyback, the company has materially increased each remaining investor’s claim on future cash flows and earnings. We’ll now examine how completing this extensive...

Lennar Corporation reported its Q4 2025 results after the market close on December 16, 2025, following a prior quarter in which it missed analysts’ revenue and adjusted operating income estimates and saw revenue fall 6.4% year on year. Investor focus has intensified ahead of this latest release because Lennar has become the most shorted stock in the consumer discretionary sector, with very large short interest in its free float. We’ll now explore how elevated short interest heading into...

Growing investor interest in American Healthcare REIT American Healthcare REIT is getting more attention as investors search for steadier ideas in a choppy market, thanks to its diversified healthcare real estate portfolio and buzz around a potential public listing. See our latest analysis for American Healthcare REIT. That backdrop helps explain the mixed recent moves, with a 7 day share price return of minus 5.3 percent and a 90 day share price return of 11.6 percent. These feed into a...

Earlier in December 2025, Crinetics Pharmaceuticals began dosing patients in its first-in-human Phase 1/2 BRAVESST2 trial of CRN09682, a nonpeptide drug conjugate targeting SST2-positive neuroendocrine and other SST2-expressing solid tumors, while also advancing atumelnant into a Phase 3 trial for congenital adrenal hyperplasia with Orphan Drug Designation. This marks an important test of Crinetics’ proprietary NDC platform, which aims to combine targeted tumor delivery with simpler...

The Milisystem S.A. ( WSE:MLM ) share price has fared very poorly over the last month, falling by a substantial 25...

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...

For many, the main point of investing in the stock market is to achieve spectacular returns. While the best companies...

The Sage Group plc ( LON:SGE ) will increase its dividend from last year's comparable payment on the 10th of February...

The main aim of stock picking is to find the market-beating stocks. But even the best stock picker will only win with...

Key Insights Insiders appear to have a vested interest in KOSESLtd's growth, as seen by their sizeable ownership 52% of...

The UK market has recently faced challenges, with the FTSE 100 and FTSE 250 indices closing lower due to weak trade data from China, highlighting global economic uncertainties. Despite these broader market pressures, investors often find potential in smaller or newer companies known as penny stocks. While the term may seem outdated, these stocks can still offer surprising value and opportunities for growth when they possess solid financial foundations.

As the United Kingdom's FTSE 100 and FTSE 250 indices experience downward pressure due to weak trade data from China, investors are increasingly cautious about the global economic landscape. In such an environment, identifying promising small-cap stocks like Concurrent Technologies can offer opportunities for those looking to navigate market volatility with a focus on companies that demonstrate resilience and potential for growth despite broader challenges.

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...

Chesapeake Utilities stock snapshot after recent pullback Chesapeake Utilities (CPK) has slipped about 6% over the past month, even as its year to date gain sits near 6%, inviting a closer look at whether the recent weakness creates opportunity. See our latest analysis for Chesapeake Utilities. That 5.8% 1 month share price pullback looks more like a breather within a still positive trend. The 90 day share price return is in the low single digits, and a solid 5 year total shareholder return...